A Queensland biotechnology company has raised US$9 million (about AUS$11.9 million) to fund the development of new types of therapeutic drugs.
22 September 2006A Member of
Privacy & Terms of use | Feedback
Authorised by: Director, Office of Marketing and Communications
ABN: 63 942 912 684
CRICOS
Provider No: 00025B